This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Next Generation CAR & T Cell Therapies

LAST CHANCE: REGISTER BY MAY 20 TO SAVE UP TO $300

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
June 14-16, 2022
Delivered as a Hybrid EventIntercontinental Mark Hopkins Hotel, San Francisco, California

Cokey Nguyen
SVP and Chief Scientific Officer at Atara Biotherapeutics Inc

Profile

Dr. Cokey Nguyen serves as Senior Vice President, Chief Scientific Officer at Atara, where he is focused on leading the development of next-generation allogeneic cell therapies for cancer and autoimmune diseases. With significant experience in research and development of cell therapies, as well as oncology drug discovery and development in biotech, Dr. Nguyen holds numerous patents for iPSC and immune effector cells and has been published in various peer-reviewed journals. He received his undergraduate degree in biology from Harvard College and Ph.D. in Immunology from Washington University in St. Louis.

Agenda Sessions

  • Keynote: A First-In-Kind, Allogeneic EBV-Targeted T-Cell Immunotherapy Approach to Treating Multiple Sclerosis

    9:15am

Speakers at this event